This is a retrospective clinical study to analyze the clinical characteristics, complications, and effects of different treatment options on long-term prognosis in patients with central nervous system tuberculosis. All cases of central nervous system tuberculosis diagnosed between 2016 and 2021 were included in the electronic medical record system of one center, and data such as demographics, hospitalization information, clinical information, laboratory or imaging examinations, treatment plans, and outcomes were collected.
Study Type
OBSERVATIONAL
Enrollment
638
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
Wuhan Pulmonary Hospital(Wuhan Institute for Tuberculosis Control)
Hubei, Wuhan, China
2-year survival rate
Calculate the 1-year survival rate and 2-year survival rate.
Time frame: 1 years,2 years
2-year disability rate
Calculate the 1-year disability rate and 2-year disability rate. Common disabilities include aphasia, hemiplegia, paraplegia, deafness, blindness, mental retardation, etc. For reference, please refer to the 《Grading of Human Injury and Disability Degree》 and 《Guidance for determination of cause-and-effect relationship between personal injury and disease》.
Time frame: 1 years,2 years
Clinical features: age of onset, mode of onset
age of onset, mode of onset
Time frame: 2 years
The presense of clinical symptoms of patients
The number and severity of clinical symptoms of patients.
Time frame: 2 years
Incidence of complications in patients with different treatment regimens
The electronic medical record system was used to collect patients' complications from baseline (admission) to 24 months, and the incidence of complications of different treatment options was compared.
Time frame: 2 years
length of hospital stay
Time frame: 2 years
proportion of patients admitted to ICU
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.